These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 26757436)
21. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios. Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488 [TBL] [Abstract][Full Text] [Related]
22. Preoperative neutrophil-to-lymphocyte ratio predicts malignancy and recurrence-free survival of solid pseudopapillary tumor of the pancreas. Yang F; Bao Y; Zhou Z; Jin C; Fu D J Surg Oncol; 2019 Aug; 120(2):241-248. PubMed ID: 31041808 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer. Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233 [TBL] [Abstract][Full Text] [Related]
24. Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma. Garcea G; Ladwa N; Neal CP; Metcalfe MS; Dennison AR; Berry DP World J Surg; 2011 Apr; 35(4):868-72. PubMed ID: 21312035 [TBL] [Abstract][Full Text] [Related]
25. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis. Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294 [TBL] [Abstract][Full Text] [Related]
26. Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China. Zhu GS; Tian SB; Wang H; Ma MG; Liu Y; Du HS; Long YP Curr Med Sci; 2018 Feb; 38(1):78-84. PubMed ID: 30074155 [TBL] [Abstract][Full Text] [Related]
27. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer. Zhang Y; Lu JJ; Du YP; Feng CX; Wang LQ; Chen MB Medicine (Baltimore); 2018 Mar; 97(12):e0144. PubMed ID: 29561419 [TBL] [Abstract][Full Text] [Related]
28. Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience. Jumeau R; Delouya G; Roberge D; Donath D; Béliveau-Nadeau D; Campeau MP Dig Liver Dis; 2018 Apr; 50(4):396-400. PubMed ID: 29326012 [TBL] [Abstract][Full Text] [Related]
29. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction. Yuan D; Zhu K; Li K; Yan R; Jia Y; Dang C J Surg Oncol; 2014 Sep; 110(3):333-40. PubMed ID: 24889121 [TBL] [Abstract][Full Text] [Related]
30. Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer. Xu SS; Li S; Xu HX; Li H; Wu CT; Wang WQ; Gao HL; Jiang W; Zhang WH; Li TJ; Ni QX; Liu L; Yu XJ World J Gastroenterol; 2020 Feb; 26(8):828-838. PubMed ID: 32148380 [TBL] [Abstract][Full Text] [Related]
31. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer. Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400 [TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Zhang Y; Jiang C; Li J; Sun J; Qu X Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119 [TBL] [Abstract][Full Text] [Related]
33. The Prognostic Role of Pretreatment Neutrophil to Lymphocyte Ratio (NLR) in Malignant Adrenal Lesions Treated With Stereotactic Body Radiation Therapy (SBRT). Mills MN; Reddy AV; Richardson L; Richardson KM; Kersh CR Am J Clin Oncol; 2019 Dec; 42(12):945-950. PubMed ID: 31569166 [TBL] [Abstract][Full Text] [Related]
34. Stage-Dependent Changes in Albumin, NLR, PLR, and AFR are Correlated with Shorter Survival in Patients with Gastric Cancer. Liu C; Li X Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532095 [TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel. Buttigliero C; Pisano C; Tucci M; Vignani F; Bertaglia V; Iaconis D; Guglielmini P; Numico G; Scagliotti GV; Di Maio M Acta Oncol; 2017 Apr; 56(4):555-562. PubMed ID: 28068151 [TBL] [Abstract][Full Text] [Related]
36. Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination Chemotherapy. Hwang GY; Baek DW; Cho HJ; Lee SJ; Chae YS; Kang BW; Lee IH; Kim JG; Seo AN; Bae HI; Park KB; Park JY; Kwon OK; Lee SS; Chung HY Anticancer Res; 2018 May; 38(5):3151-3156. PubMed ID: 29715156 [TBL] [Abstract][Full Text] [Related]
37. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor. Kang M; Jeong CW; Kwak C; Kim HH; Ku JH Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452 [TBL] [Abstract][Full Text] [Related]
38. Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pancreatic cancer. Guo J; Wu M; Guo L; Zuo Q Bull Cancer; 2018 Feb; 105(2):146-154. PubMed ID: 29290332 [TBL] [Abstract][Full Text] [Related]
39. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Wang DS; Luo HY; Qiu MZ; Wang ZQ; Zhang DS; Wang FH; Li YH; Xu RH Med Oncol; 2012 Dec; 29(5):3092-100. PubMed ID: 22476808 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]